IL2, interleukin 2, 3558

N. diseases: 950; N. variants: 5
Disease: Multiple sclerosis relapse ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0856120
Disease: Multiple sclerosis relapse
Multiple sclerosis relapse 		0.010 Biomarker disease BEFREE Daclizumab is a monoclonal antibody that binds the high-affinity interleukin-2 receptor and was approved for the treatment of relapsing multiple sclerosis. 30657420 2019